BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2026 6:06:26 AM | Browse: 40 | Download: 108
 |
Received |
|
2025-09-22 02:01 |
 |
Peer-Review Started |
|
2025-09-22 02:01 |
 |
First Decision by Editorial Office Director |
|
2025-10-29 09:20 |
 |
Return for Revision |
|
2025-10-29 09:20 |
 |
Revised |
|
2025-11-06 17:24 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-29 02:32 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-29 06:56 |
 |
Articles in Press |
|
2025-12-29 06:56 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-01-23 08:23 |
 |
Publish the Manuscript Online |
|
2026-03-15 06:06 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Leukoplakia of oral cavity and urinary bladder are premalignant to squamous carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohamed Wishahi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed Wishahi, MD, PhD, Professor, Department of Urology, Theodor Bilharz Research Institute, Embaba, Giza, Cairo 12411, Egypt. moh.weshahy@gmail.com |
| Key Words |
Leukoplakia; Squamous cell carcinoma; Programmed cell death-ligand 1; Immune checkpoint inhibitors; Oral cancer; Bladder cancer |
| Core Tip |
Oral leukoplakia and urinary bladder leukoplakia are premalignant lesions that progress to squamous cell carcinoma (SCC), both lesions and their corresponding SCC express programmed cell death-ligand 1 (PD-L1) indicating response to PD-L1 inhibitors. A recent approach with consideration of recent finding of expression of PD-L1, genetic analysis, microenvironment landscape, recruited clinical trials, and animal model studies would advocate possible treatment of oral leukoplakia with PD-L1 inhibitors aiming at cure and prevent progression to SCC. |
| Publish Date |
2026-03-15 06:06 |
| Citation |
Wishahi M. Leukoplakia of oral cavity and urinary bladder are premalignant to squamous carcinoma. World J Exp Med 2026; 16(1): 114526 |
| URL |
https://www.wjgnet.com/2220-315x/full/v16/i1/114526.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v16.i1.114526 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.